SXTP
NASDAQ · Pharmaceuticals
60 Degrees Pharma Inc
$1.12
-0.03 (-2.61%)
Open$1.15
Previous Close$1.15
Day High$1.19
Day Low$1.08
52W High$8.62
52W Low$1.05
Volume—
Avg Volume175.7K
Market Cap3.06M
P/E Ratio—
EPS$-9.79
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+137.5% upside
Current
$1.12
$1.12
Target
$2.66
$2.66
$2.13
$2.66 avg
$3.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.54M | 3.95M | 862.6K |
| Net Income | -28,971,783 | -18,596,822 | 198.9K |
| Profit Margin | -522.7% | -496.6% | 23.1% |
| EBITDA | -30,349,019 | -20,563,132 | 334.7K |
| Free Cash Flow | — | — | 224.8K |
| Rev Growth | +40.2% | +40.2% | -6.7% |
| Debt/Equity | 0.04 | 0.04 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |